Product Information

CARISOPRODOL 250 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.5837 per EA under NDC 51525590101. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARISOPRODOL 250 MG TABLET

carisoprodol
$0.5837per EA
DEA Schedule CIV

Strength

250 mg/1

NDC

51525590101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CARISOPRODOL

Approval Type

Authorized Generic (NDA)

FDA Application

NDA011792

FDA Approved

Before 1982

TE Code

AB

On Market Since

10/1/2016

Pharmacological Classes

Centrally-mediated Muscle Relaxation
Muscle Relaxant

Price Statistics

The NADAC for CARISOPRODOL 250 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 77.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5837 per EA
All-time high$2.7381 (Mar 15, 2017)
All-time low$0.3644 (Jul 22, 2026)
52-week high$0.5837
52-week low$0.3644
Median price$1.2983
Average price$1.4477
Largest weekly change+80.1% (Aug 17, 2022)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+9.9%

1M

+23.2%

3M

+46.9%

6M

+42.8%

1Y

+17.8%

3Y

+26.6%

5Y

-55.0%

All

-77.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CARISOPRODOL 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARISOPRODOL 250 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.5837 per EA (NDC 51525590101), effective Nov 18, 2026.

How has the price of CARISOPRODOL 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARISOPRODOL 250 MG TABLET has declined 77.3%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CARISOPRODOL 250 MG TABLET?

Since Nov 28, 2013, the NADAC for CARISOPRODOL 250 MG TABLET has ranged from a low of $0.3644 (Jul 22, 2026) to a high of $2.7381 (Mar 15, 2017), with a median of $1.2983 per EA.

Are there cheaper alternatives to CARISOPRODOL 250 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARISOPRODOL 250 MG TABLET, is $0.5565 per EA — about 5% below CARISOPRODOL 250 MG TABLET.

Who manufactures CARISOPRODOL 250 MG TABLET?

CARISOPRODOL 250 MG TABLET (NDC 51525590101) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.